Healthcare -
Biotechnology - NASDAQ - US
$ 14.24
0.636 %
$ 1.16 B
Market Cap
-4.25
P/E
VRDN - CASH FROM OPERATIONS
Cash from Operations VRDN - Viridian Therapeutics, Inc.
-232 M
LAST VALUE
-57.35%
2 YEAR CAGR
-45.15%
5 YEAR CAGR
-59.26%
10 YEAR CAGR